Only half of preterm infants treated with antenatal steroids are affected, i.e. do not develop respiratory distress syndrome. We have devised a method for determining whether the infant has responded before delivery. Additional patients are needed to validate the methodology and to further develop a genetic test based on the original functional assay of estriol. The genetic marker will improve the diagnosis and provide information to develop specific therapies.""""""""
Showing the most recent 10 out of 1232 publications